ATE530915T1 - Freisetzungsreagens für vitamin-d-verbindungen - Google Patents

Freisetzungsreagens für vitamin-d-verbindungen

Info

Publication number
ATE530915T1
ATE530915T1 AT06805885T AT06805885T ATE530915T1 AT E530915 T1 ATE530915 T1 AT E530915T1 AT 06805885 T AT06805885 T AT 06805885T AT 06805885 T AT06805885 T AT 06805885T AT E530915 T1 ATE530915 T1 AT E530915T1
Authority
AT
Austria
Prior art keywords
vitamin
compounds
reagent
hydroxyvitamin
release reagent
Prior art date
Application number
AT06805885T
Other languages
English (en)
Inventor
Apostolos Kyriatsoulis
Susanne Feldmann
Erasmus Huber
Uwe Kobold
Angela Puhlmann
Proff Leopold Von
Nicole Horn
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35427234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE530915(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE530915T1 publication Critical patent/ATE530915T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34—Purifying; Cleaning
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06805885T 2005-09-29 2006-09-27 Freisetzungsreagens für vitamin-d-verbindungen ATE530915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05021246 2005-09-29
PCT/EP2006/009361 WO2007039194A1 (en) 2005-09-29 2006-09-27 Release reagent for vitamin d compounds

Publications (1)

Publication Number Publication Date
ATE530915T1 true ATE530915T1 (de) 2011-11-15

Family

ID=35427234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06805885T ATE530915T1 (de) 2005-09-29 2006-09-27 Freisetzungsreagens für vitamin-d-verbindungen

Country Status (10)

Country Link
US (2) US20090093445A1 (de)
EP (1) EP1931999B1 (de)
JP (1) JP4852614B2 (de)
CN (1) CN101273272B (de)
AT (1) ATE530915T1 (de)
CA (1) CA2624129C (de)
DK (1) DK1931999T3 (de)
ES (1) ES2374942T3 (de)
PL (1) PL1931999T3 (de)
WO (1) WO2007039194A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2649338C (en) * 2006-06-06 2011-07-12 F.Hoffman-La Roche Ag Improved measurement of vitamin d
GB0709322D0 (en) * 2007-05-15 2007-06-20 Nordic Bioscience As Exposure agent for detection of vitamin d
US20110097733A1 (en) 2009-10-27 2011-04-28 Michel Anciaux Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite
KR101494952B1 (ko) * 2010-05-20 2015-02-23 에프. 호프만-라 로슈 아게 비타민 d 화합물용 방출 시약
EP2635611B1 (de) * 2010-12-28 2017-01-11 Future Diagnostics B.V. Freisetzungsreagens für vitamin d
US9052308B2 (en) 2011-01-07 2015-06-09 The General Hospital Corporation Assays and methods of treatment relating to vitamin D insufficiency
EP2661632B1 (de) * 2011-01-07 2018-03-07 The General Hospital Corporation Assays und verfahren für eine behandlung im zusammenhang mit vitamin-d-mangel
WO2014179737A2 (en) 2013-05-03 2014-11-06 The General Hospital Corporation Assays and methods of treatment relating to vitamin d insufficiency
TW201250248A (en) * 2011-04-25 2012-12-16 Kyowa Medex Co Ltd Prognostication method of renal failure
US8785603B2 (en) 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
JP6038945B2 (ja) 2011-11-18 2016-12-07 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ビタミンｄ化合物に関する遊離試薬
US9244083B2 (en) * 2012-11-30 2016-01-26 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting vitamin D
CN103163306B (zh) * 2013-02-05 2015-06-17 北京九强生物技术股份有限公司 25羟维生素d检测试剂盒及其制备方法
KR101840525B1 (ko) 2013-02-06 2018-03-20 후지레비오 가부시키가이샤 비타민 d 의 측정 방법 및 측정용 키트
WO2014122974A1 (ja) * 2013-02-06 2014-08-14 富士レビオ株式会社 カオトロピック剤を利用するビタミンｄの測定方法
US9618523B2 (en) 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
US20140273021A1 (en) 2013-03-14 2014-09-18 Enzo Biochem, Inc. Vitamin d assays
DE102013205055A1 (de) 2013-03-21 2014-09-25 Orgentec Diagnostika Gmbh Verfahren und Reagenz zur Bestimmung von Vitamin D Metaboliten
CN105556313B (zh) * 2013-09-17 2018-08-24 生物梅里埃公司 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途
KR102425339B1 (ko) 2014-12-08 2022-07-25 에프. 호프만-라 로슈 아게 비타민 d 의 측정을 위한 방법
WO2017039574A1 (en) * 2015-08-28 2017-03-09 Enzo Life Sciences, Inc. Vitamin d assays
WO2017127833A1 (en) 2016-01-22 2017-07-27 Affimedix, Inc. Device for detection of vitamin d metabolites
CN109863406B (zh) * 2016-07-29 2023-04-14 Diazyme研究室有限公司 用于测定维生素d的方法和成分
KR102042609B1 (ko) * 2017-05-11 2019-11-08 바디텍메드(주) 측방유동 카트리지에서 형광측정법을 이용한 비타민 d의 신속 정량 검사법
EP3401681B1 (de) * 2017-05-11 2023-03-29 Boditech Med Inc. Verfahren zur schnellen quantitativen bestimmung von vitamin d auf der basis einer fluoreszenzmessung unter verwendung einer lateralen strömungskartusche
CN108089015B (zh) * 2017-12-18 2020-07-24 郑州安图生物工程股份有限公司 用于检测人血清样品中25羟基维生素d含量的释放剂及其检测方法
CN110058028B (zh) * 2019-05-05 2021-03-02 苏州长光华医生物医学工程有限公司 一种24,25-双羟基维生素d免疫检测试剂盒及其应用
CN113495159A (zh) * 2020-03-20 2021-10-12 郑州达诺生物技术有限公司 一种系统反应液、一种25羟基维生素d定量检测试剂盒及其使用方法
CN113884687B (zh) * 2021-12-08 2022-02-11 南京岚轩生物科技有限公司 用于检测25-羟基维生素d含量的解离剂及其制备方法
CN115774111A (zh) * 2022-12-20 2023-03-10 江苏拜明生物技术有限公司 一种25-羟基维生素d的检测方法及试剂盒
CN119716094B (zh) * 2024-12-25 2025-11-14 珠海丽珠试剂股份有限公司 一种用于25-羟基维生素d检测的磁珠稀释液和试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE68925951T2 (de) * 1988-12-27 1996-07-25 Lepetit Spa Chemisches Verfahren zur Herstellung des Antibiotikums L 17392 (Deglukoteicoplanin) und dessen Salze
JPH06109727A (ja) 1992-08-14 1994-04-22 Wisconsin Alumni Res Found １，２５−ジヒドロキシビタミンｄの検定法
JP2968910B2 (ja) * 1993-07-14 1999-11-02 ヤマサ醤油株式会社 １α，２５（ＯＨ）２ビタミンＤ３に対する抗体及びその用途
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5821020A (en) 1995-07-14 1998-10-13 Nhh Biologics Vitamin D assay
US6060311A (en) * 1995-07-28 2000-05-09 The Regents Of The University Of California Retinoid suppression of ventricular muscle cell hypertrophy
DE873126T1 (de) 1995-12-29 2000-11-02 A And D Assay, Inc. Markierte vitamin d-verbindungen und deren verwendung
WO1999067211A1 (de) 1998-06-25 1999-12-29 Immundiagnostik Gesellschaft Für Produktion Und Vertrieb Von Labordiagnostika Mbh FUNKTIONELLE VITAMIN-D-DERIVATE UND VERFAHREN ZUR BESTIMMUNG VON 25-HYDROXY- UND 1α,25-DIHYDROXY-VITAMIN-D
JP2002107350A (ja) * 2000-10-03 2002-04-10 Nippon Zoki Pharmaceut Co Ltd ５−ヒドロキシクレアチニンの測定法
GB0029729D0 (en) 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
DE10144905C2 (de) 2001-09-12 2003-07-31 Immundiagnostik Ag Bestimmung von Vitamin-D direkt in Serum oder Plasma
US7776544B2 (en) * 2002-06-10 2010-08-17 Scimed Technologies Inc. Extraction and quantification of vitamins A & D in fluid samples
US20040054160A1 (en) * 2002-09-16 2004-03-18 Santona Pal Nucleic-acid ink compositions for arraying onto a solid support
US20040132104A1 (en) 2003-01-07 2004-07-08 Sackrison James L. Vitamin D assay

Also Published As

Publication number Publication date
EP1931999A1 (de) 2008-06-18
JP4852614B2 (ja) 2012-01-11
CN101273272B (zh) 2012-11-07
PL1931999T3 (pl) 2012-03-30
JP2009510415A (ja) 2009-03-12
EP1931999B1 (de) 2011-10-26
DK1931999T3 (da) 2012-01-30
US20090093445A1 (en) 2009-04-09
US20150104876A1 (en) 2015-04-16
CA2624129A1 (en) 2007-04-12
WO2007039194A1 (en) 2007-04-12
US9341552B2 (en) 2016-05-17
HK1124919A1 (en) 2009-07-24
ES2374942T3 (es) 2012-02-23
CN101273272A (zh) 2008-09-24
CA2624129C (en) 2011-03-29

Similar Documents

Publication Publication Date Title
ATE530915T1 (de) Freisetzungsreagens für vitamin-d-verbindungen
EP4249605A3 (de) Verfahren zum nachweis von analyten
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
IL251791A0 (en) Ovarian cancer biomarkers: ctap3-related proteins
WO2009108905A3 (en) Fluorescence polarization herg assay
MX2011009020A (es) Ensayo sin separacion con inhibidores de señal selectiva.
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
ZA201109222B (en) Analysis and assay of glycated haemoglobins by capillary electrophoresis, buffer compositions, and kits for capillary electrophoresis
ES2674177T3 (es) Preparación de suero
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
WO2008003024A3 (en) Method and composition for diagnosing endometrial cancer
WO2006087163A3 (en) Novel in vitro methods for studying receptors recognizing volatile compounds
BRPI0719529B8 (pt) método para produzir uma preparação sólida
BRPI0510561A (pt) epìtopos que induzem morte de célula t
WO2007002527A3 (en) BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2006102526A3 (en) Identification of biomarkers by serum protein profiling
GT200600026A (es) Metodo para analizar el acido fosforoso, el fosetil-al o ambos simultaneamente
MX2007013108A (es) Reactivos que enlazan ccx-ckr2.
TW200643177A (en) Method and kits for detecting genetically modified organism (GMO)
WO2007056047A3 (en) Antibodies, assays and kits to quantitate cartilage destruction
EA200801476A1 (ru) Замещенные аминофенилсульфонамидные соединения в качестве ингибиторов протеазы вич
ATE508367T1 (de) Katecholamin-assay

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1931999

Country of ref document: EP